Southern Research Drug Discovery Continues J-1 Scholar Training Program
August 13, 2015 | Southern Research
Since its founding in 1941, Southern Research has been actively participating in training the next generation of scientists. Various faculty members in Southern Research’s drug discovery division hold academic appointments in departments at the University of Alabama at Birmingham (UAB) School of Medicine. They also serve as training members of the UAB Graduate School.
Over the years, numerous graduate students have completed their doctoral thesis research in Southern Research labs. In addition, postdoctoral training is a major training mission in the drug discovery division. Many Southern Research postdoctoral trainees have advanced their scientific careers to become independent researchers in both academia and industry.
In October 2013, Southern Research, in collaboration with the American Immigration Council, initiated a J-1 Visa training program for international trainees. The program allows international interns and trainees to work in Southern Research labs for up to 18 months of training on biomedical research.
“Training international scholars further fulfils Southern Research’s mission of education and creates potential international collaborations for research in precision medicine in the future,” said Bo Xu, M.D., Ph.D., Southern Research’s cancer research department chairman.
Chunling Jiang, M.D., of Jiangxi Provincial Cancer Hospital in China, was the first to complete her one-year training in the oncology groups in fall 2014. Dr. Jiang is a seasoned radiation oncologist interested in developing novel approaches to helping cancer patients receiving radiotherapy. With bench-to-bedside training, she gained the knowledge and skills to conduct translational oncology research. Shang Cai, M.D. and Ph.D. candidate, from Soochow University in China is currently conducting training in the oncology groups at Southern Research.
For additional information about the program, contact Dr. Bo Xu, in the Southern Research Drug Discovery Oncology department.
Moving Science, Drug Discovery, In The News, Industry Insights
Rita Cowell is chair of Southern Research’s Neuroscience Department.
A Southern Research neuroscience lab has received new federal grants totaling almost $3.9 million to advance its study of Parkinson’s Disease and other neurological diseases.
The grants from the National Institute of Neu...
Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission
TNX-1800 is Based on a Proprietary Vaccine Platform Designed to Stimulate Long Term T cell Immunity
CHATHAM, NJ, March 25, 2021 – ...
Inside a high-tech laboratory at Southern Research, a team led by Robert Bostwick, Ph.D., is screening vast numbers of compound samples to identify agents that could become a new treatment for COVID-19, the disease caused by the novel coronavirus.
Bostwick is director of Southern Research’s state...